Fusion event
HBV-ME3-DT integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACC| |AGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACA
End
86454443/86743401 (Hg38)
Nearest miRNA
hsa-mir-10392/Upstream/465003; hsa-let-7a-2/Downstream/1433101;
Upstream sequence
TCTGACAGCCCGTTGCCACAGAGCACCACCCACAGAGCAGAGGATCCACACTCAGTATTACATAGCATCAGCAGAAACAGAGGCTGACCCCCTTGGTGAG
Downstream sequence
GCCACTTCAGTTTCCTTGTTCTTGGGCCACCCATGAGCACCTCTGACAGTTTAAAAGATACTCTTACAAGCCAAAGGAGAGAAGTATAGCCCAGGATTCC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.